These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38306091)

  • 1. Associations Between Annual Medicare Part D Low-Income Subsidy Loss and Prescription Drug Spending and Use.
    Fung V; Price M; Cheng D; Patel TA; Yang Z; Hsu J; Alegria M; Newhouse JP
    JAMA Health Forum; 2024 Feb; 5(2):e235152. PubMed ID: 38306091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consequences of forgoing prescription drug subsidies among low-income Medicare beneficiaries with diabetes.
    Glynn A; Hernandez I; Roberts ET
    Health Serv Res; 2022 Oct; 57(5):1136-1144. PubMed ID: 35430735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognition and take-up of subsidized drug benefits by Medicare beneficiaries.
    Kuye IO; Frank RG; McWilliams JM
    JAMA Intern Med; 2013 Jun; 173(12):1100-7. PubMed ID: 23649604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sociodemographic and spending characteristics of Medicare beneficiaries taking prescription drugs subject to price negotiations.
    Odouard IC; Anderson GF; Alexander GC; Ballreich J
    J Manag Care Spec Pharm; 2024 Mar; 30(3):269-278. PubMed ID: 38140901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
    Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
    J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affordability and adherence gains for Medicare Part D low-income subsidy recipients when low-income subsidy benefits expanded in 2024.
    Stuart BC; Loh FE; Dougherty JS
    J Manag Care Spec Pharm; 2024 Jul; 30(7):728-735. PubMed ID: 38950158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
    Hwang TJ; Jain N; Lauffenburger JC; Vokinger KN; Kesselheim AS
    JAMA Intern Med; 2019 Mar; 179(3):374-380. PubMed ID: 30640379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis.
    Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
    J Manag Care Spec Pharm; 2015 Oct; 21(10):956-64. PubMed ID: 26402394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of low-income subsidy, medicaid dual eligibility, and disability status with high-risk medication use among Medicare Part D beneficiaries.
    Chinthammit C; Bhattacharjee S; Lo-Ciganic WH; Axon DR; Slack M; Bentley JP; Warholak TL
    Res Social Adm Pharm; 2022 Apr; 18(4):2634-2642. PubMed ID: 34006485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare Part D low-income subsidies expanded in January 2024, but more needs to be done to ensure that eligible beneficiaries enroll.
    Loh FE; Stuart BC; Hunt RJ; Negari M
    J Manag Care Spec Pharm; 2024 Mar; 30(3):279-289. PubMed ID: 38324387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.
    Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF
    BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year impact of Medicare Part D coverage gap reform on drug expenditures and utilization.
    Park J; Look KA
    Health Serv Res; 2022 Feb; 57(1):56-65. PubMed ID: 33870486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act.
    Narasimmaraj PR; Oseran A; Tale A; Xu J; Essien UR; Kazi DS; Yeh RW; Wadhera RK
    J Am Coll Cardiol; 2023 Apr; 81(15):1491-1501. PubMed ID: 37045519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential savings associated with drug substitution in Medicare Part D: the Translating Research into Action for Diabetes (TRIAD) study.
    Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF; Fu J; Simien L; Tseng CW
    J Gen Intern Med; 2014 Jan; 29(1):230-6. PubMed ID: 23975059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM
    JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicaid Eligibility Loss Among Dual-Eligible Beneficiaries Before and During COVID-19 Public Health Emergency.
    Ma Y; Roberts ET; Johnston KJ; Orav EJ; Figueroa JF
    JAMA Netw Open; 2024 Apr; 7(4):e245876. PubMed ID: 38602676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subsidies for Oral Chemotherapy and Use of Immunomodulatory Drugs Among Medicare Beneficiaries With Myeloma.
    Olszewski AJ; Dusetzina SB; Eaton CB; Davidoff AJ; Trivedi AN
    J Clin Oncol; 2017 Oct; 35(29):3306-3314. PubMed ID: 28541791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of out-of-pocket costs on initiation of disease-modifying therapies among medicare beneficiaries with multiple sclerosis.
    Hartung DM; Johnston KA; McGregor JC; Bourdette DN
    Mult Scler Relat Disord; 2020 Nov; 46():102554. PubMed ID: 33032059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between the low-income subsidy and cost-related nonadherence to drug therapies in Medicare Part D.
    Wei II; Lloyd JT; Shrank WH
    J Am Geriatr Soc; 2013 Aug; 61(8):1315-23. PubMed ID: 23889465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.
    Safran DG; Strollo MK; Guterman S; Li A; Rogers WH; Neuman P
    J Gen Intern Med; 2010 Jan; 25(1):10-7. PubMed ID: 19882193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.